Christoph Prusseit to Leave Medios AG Management Board

Berlin, September 14, 2026 – Christoph Prusseit, Chief Business Officer Germany and Member of the Management Board at Medios AG, has announced he will not extend his contract beyond its expiry on July 31, 2027. This decision is due to personal reasons. The Supervisory Board expressed regret over his departure and thanked him for his significant contributions, particularly in strengthening patient-specific therapies and pharmaceutical supply in Germany.

Prusseit has been instrumental in advancing the company's position as a leading German Specialty Pharma firm over his eight-year tenure. He emphasized the importance of the ongoing transformation at Medios for the company's future success. Prusseit will stay in his current role until the end of the year to ensure a smooth transition and will later continue as an advisor.